|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
German Clinical Trials Register |
|
Last refreshed on:
|
8 April 2024 |
|
Main ID: |
DRKS00007776 |
|
Date of registration:
|
05/02/2015 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Clinical and Laboratory Online Patient- and Research Registry for Primary Immunodeficiencies
of the European Society for Immunodeficiencies (ESID)
|
|
Scientific title:
|
Clinical and Laboratory Online Patient- and Research Registry for Primary Immunodeficiencies
of the European Society for Immunodeficiencies (ESID)
- ESID Registry |
|
Date of first enrolment:
|
11/12/2014 |
|
Target sample size:
|
30000 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://drks.de/search/en/trial/DRKS00007776 |
|
Study type:
|
observational |
|
Study design:
|
Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: other
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Austria
|
Belgium
|
Croatia
|
Czechia
|
Egypt
|
France
|
Germany
|
Hungary
|
|
Iran
|
Ireland
|
Israel
|
Italy
|
Netherlands
|
Poland
|
Slovakia
|
Slovenia
|
|
Spain
|
Switzerland
|
United Kingdom
| | | | | |
|
Contacts
|
|
Name:
|
Gerhard
Kindle |
|
Address:
|
Breisacher Str. 115
79106
Freiburg
Germany |
|
Telephone:
|
0761 270 36961 |
|
Email:
|
esid-registry@uniklinik-freiburg.de |
|
Affiliation:
|
Institut für Immundefizienz (CCI) Universitätsklinikum Freiburg |
|
|
Name:
|
Gerhard
Kindle |
|
Address:
|
Breisacher Str. 115
79106
Freiburg
Germany |
|
Telephone:
|
0761 270 36961 |
|
Email:
|
esid-registry@uniklinik-freiburg.de |
|
Affiliation:
|
Institut für Immundefizienz (im CCI) Universitätsklinikum Freiburg |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Diagnosis of a primary immunodeficiency
Exclusion criteria: Diagnosis of a secondary immunodeficiency
Age minimum:
None
Age maximum:
None
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Common variable immunodeficiency
|
|
Immunodeficiency associated with other major defects
|
|
Combined immunodeficiencies
|
|
Immunodeficiency with predominantly antibody defects
|
D84
D80
D81
D82
D83
|
|
Other immunodeficiencies
|
|
Intervention(s)
|
Group 1: Baseline documentation: Age, sex, familial cases, first symptoms, diagnosis, haemtopoietic stem cell transplantation (HSCT), immunoglobulin replacement (Ig replacement), lab values, clinical features; Yearly follow-up: living status, therapy status (HSCT, Ig replacement), changes to diagnosis, lab values, clinical features
|
|
Primary Outcome(s)
|
|
Determine the epidemiology of primary immunodeficiencies (PID)
|
|
Secondary Outcome(s)
|
|
Correlation of clinical features, life expectancy, complications, medication effects
|
|
Source(s) of Monetary Support
|
|
European Society for Immunodeficiencies (ESID)c/o Kenes Education B.V.
|
|
Ethics review
|
Status: Approved
Approval date: 11/12/2014
Contact:
ekfr.mpg@uniklinik-freiburg.de
Ethik-Kommission der Albert-Ludwigs-Universität Freiburg
+49-761-27072600
ekfr.mpg@uniklinik-freiburg.de
|
|